New York State Common Retirement Fund’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-260,562
Closed -$47.9M 3650
2021
Q2
$47.9M Sell
260,562
-17,638
-6% -$3.24M 0.05% 335
2021
Q1
$42.5M Sell
278,200
-90,942
-25% -$13.9M 0.05% 359
2020
Q4
$57.7M Sell
369,142
-129,381
-26% -$20.2M 0.06% 282
2020
Q3
$57M Sell
498,523
-1,410
-0.3% -$161K 0.07% 256
2020
Q2
$56.1M Sell
499,933
-141,262
-22% -$15.9M 0.07% 265
2020
Q1
$57.6M Sell
641,195
-19,409
-3% -$1.74M 0.09% 213
2019
Q4
$71.4M Sell
660,604
-11,570
-2% -$1.25M 0.08% 222
2019
Q3
$65.8M Buy
672,174
+7,434
+1% +$728K 0.08% 232
2019
Q2
$87.1M Sell
664,740
-3,261
-0.5% -$427K 0.11% 192
2019
Q1
$90.3M Buy
668,001
+47,506
+8% +$6.42M 0.12% 167
2018
Q4
$60.4M Sell
620,495
-8,256
-1% -$804K 0.09% 219
2018
Q3
$87.4M Buy
628,751
+25,642
+4% +$3.56M 0.1% 190
2018
Q2
$74.9M Buy
603,109
+37,461
+7% +$4.65M 0.09% 202
2018
Q1
$63M Sell
565,648
-11,599
-2% -$1.29M 0.08% 244
2017
Q4
$69M Buy
577,247
+10,698
+2% +$1.28M 0.08% 230
2017
Q3
$79.5M Hold
566,549
0.1% 203
2017
Q2
$68.9M Sell
566,549
-10,585
-2% -$1.29M 0.09% 219
2017
Q1
$70M Sell
577,134
-3,195
-0.6% -$387K 0.09% 212
2016
Q4
$71M Buy
580,329
+12,280
+2% +$1.5M 0.1% 197
2016
Q3
$69.6M Sell
568,049
-54,404
-9% -$6.67M 0.1% 197
2016
Q2
$72.7M Buy
622,453
+22,369
+4% +$2.61M 0.11% 187
2016
Q1
$83.5M Sell
600,084
-40,400
-6% -$5.62M 0.13% 156
2015
Q4
$122M Sell
640,484
-22,050
-3% -$4.21M 0.19% 106
2015
Q3
$104M Buy
662,534
+2,794
+0.4% +$437K 0.16% 122
2015
Q2
$119M Buy
659,740
+39,059
+6% +$7.06M 0.17% 118
2015
Q1
$108M Buy
620,681
+10,902
+2% +$1.89M 0.16% 134
2014
Q4
$113M Sell
609,779
-65,754
-10% -$12.2M 0.17% 130
2014
Q3
$112M Sell
675,533
-16,413
-2% -$2.72M 0.17% 122
2014
Q2
$108M Buy
691,946
+65,416
+10% +$10.2M 0.16% 130
2014
Q1
$95.3M Buy
626,530
+59,450
+10% +$9.04M 0.15% 143
2013
Q4
$75.5M Sell
567,080
-61,000
-10% -$8.12M 0.12% 179
2013
Q3
$73M Sell
628,080
-12,220
-2% -$1.42M 0.12% 167
2013
Q2
$59.1M Buy
+640,300
New +$59.1M 0.1% 200